Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
69 Cards in this Set
- Front
- Back
Alterations in immunity |
Excessive immune response Deficient immune response |
|
Excessive immune response types |
Autoimmune disorders Hypersensitivity |
|
Auto immune disorders is a general term used when ___. Caused by ___. Occurs due to __ |
The immune system attacks your own cells Genetic or environmental factors Failure to recognize self-antigens |
|
Hypersensitivity is a ___ or is ___. Immune system may ___. |
Normal immune response that is excessive Or is triggered by non-pathogenic antigens Respond to a normally harmless substance |
|
Normally harmless substance the immune system may respond to |
Allergens |
|
Type 1 hypersensitivity is caused by |
Genetics |
|
Type 1 hypersensitivity is so known as ___ because ___. |
Immediate-type hypersensitivity Signs and symptoms occur within 15-30 min if exposure to antigen or allergen |
|
Type 1 hypersensitivity is also called |
Anaplaxis or atopic hypersensitivity |
|
Type 1 hypersensitivity is mediated by |
IgE |
|
Type 1 hypersensitivity principal effecor cell |
Mast vekl |
|
Type 1 hypersensitivity pathogenesis: First exposure Second exposure Release of |
First exposure to antigen caused production of IgE antibodies which are then out on the surface of mast cells Second exposure may cause immediate degranulation of mast cells, which triggers an inflammatory response Release of histamines and other chemical mediators |
|
Examples of Type 1 hypersensitivity (7) |
Allergic rhinitis Allergic asthma Atopic dermititis Food allergy Insect stings Medications Vaccines |
|
Allergic rhinitis+ caused by + Tx |
Nasal allergy Caused by pollen spores, house dust mites, animal dander/feathers etc Tx: anihistamines Desensitization by low dose exposure |
|
What does low dose exposure do |
Causes the development of IgG which bind to allergens before they can bind to IgE and cause mast cell degranulation |
|
Anaphylaxis +occurs due to + Tx |
Life threatening form of Type 1 hypersensitivity Occurs due to release of histamine Epinephrine, antihistamines, oxygen, corticosteroids |
|
What does epinephrine do |
Constricts blood vessels and causes bronchodilation |
|
Type 2 hypersensitivity is also known as |
Cytotoxic or tissue specific hypersensitivity |
|
In Type 2 hypersensitivity Antibodies |
Attack antigens on the surface of specific cells or tissues activating complement if CMI cytotoxicity |
|
Type 2 hypersensitivity can occur within |
15-30 min of exposure but is usually much slower to develop |
|
Type 2 hypersensitivity is mediated by |
IgG or IgM Antibodies |
|
Type 2 hypersensitivity pathogenesis |
Then antigen antibody binding activates complement IgG or IgM Antibodies bind to antigens located on the surface of cellsThen antigen antibody binding activates complementLysis of the cell with antigens occurs via complement or is phagocytized cellsThen antigen antibody binding activates complementLysis of the cell with antigens occurs via complement or is phagocytized Lysis of the cell with antigens occurs via complement or is phagocytized |
|
Examples of Type 2 hypersensitivity (8) |
ABO transfusion reaction Hemolytic disease of newborns (Rh incompatibility) Myasthenia gravis Thyroiditis Graves disease Acute graft rejection Autoimmune hemolytic anemia Type 1 diabetes |
|
Myasthenia gravis |
Antibodies form that bind to acetylcholine receptors |
|
Gabe's disease |
Antibodies bind to TSH receptors |
|
Type 3 hypersensitivity is also known as |
Immune complex disorder or arthus reaction |
|
Type 3 hypersensitivity is when a ___ forms that is __. It is then __. |
Antigen-antibody complex forms that is insoluble. It is then deposited in tissues which then causes inflammatory reaction |
|
Type 3 hypersensitivity occurs (time) |
Hours after exposure |
|
Type 3 hypersensitivity mediated by |
IgG or IgM |
|
Type 3 hypersensitivity pathogenesis (5) |
°Antigen-antibody complex forms °Complex becomes insoluble and precipitates out if blood and into tissue °Triggers complement in the tissue which triggers inflammation °Inflammation leads to tissue destruction, scarring, further attack against damaged tissue °note that tissue damage is due to inflammation and infiltration of inflammatory cells |
|
Exapmles of Type 3 hypersensitivity (3) |
Systemic lupus erythematosus Immune complex glomerulonephritis Rheumatoid arthritis |
|
Systemic lupus erythematosus |
Antibodies develop to nuclear antigens (DNA and RNA) Affects multiple organ systems: joint swelling, pain, skin lesions cardiac, renal, CNS involvement classic butterfly rash |
|
Type 4 hypersensitivity is also known as |
Delayed-type hypersensitivity or cell-mediated hypersensitivity |
|
Type 4 hypersensitivity mediated by |
Cells |
|
Type 4 hypersensitivity usually occurs |
24 hours to 14 days after exposure |
|
Delayed cell reaction in Type 4 hypersensitivity causes |
Tissue damage |
|
Type 4 hypersensitivity pathogenesis (3) |
°Antigen processed by presenting cell and presented to helper T cells °Cytokines from helper T cells activate macrophages and stimulate cytotoxic T cells °Macrophages and cytokines T cells migrate to area of antigen and cause cell destruction |
|
Examples of Type 4 hypersensitivity (5) |
Contact hypersensitivity Tuberculin test Chronic transplant rejection Graft-virus-host disease Granulomatous hypersensitivity |
|
Contact hypersensitivity is + slow to develop because+ causes |
Allergic response to a variety of plant oils, chemicals, ointments, clothing, cosmetics, dyes, adhesives Slow to develop because happen must penetrate epidermis and combine with normal epidemiology protein to form Antigen Erythems, edema, pruritus, blisters |
|
Tuberculin test |
Myoplasma tuberculosis antigen injected into dermis Positive results indicate previous exposure to M. Tuberculosis enough to cause hypersensitivity reaction. Does not necessarily mean you have active TB |
|
Tx for chronic transplant rejection |
Immune suppressants |
|
Graft-verses-host disease +Ex |
Immune suppressed host attacked by T-lymphocyte from donor tissue They attack host antigen as foreign Ex bone marrow transplant |
|
Granulomatous hypersensitivity |
Caused by persistent antigen Macrophages are unable to destroy. Wall off Ag in connective tissue. Inflammatory cells form a mass called granuloma Over time center of granuloma can undergo necrosis Eventually fibroblasts produce collagen and make the granuloma fibrotic w/ scar tissue |
|
Immunodeficiency due to + first clinical indicators + in children |
Due to one or more components of immune system not functioning Infections In children first see as recurrent or untreatable infections |
|
Immunodeficiency 2 examples |
SCID severe combined immunodeficiency disorder B-cell disorders |
|
SCID |
Lack of T-cells and sometimes also B-cells Group of disorders Genetically determined |
|
B-cell disorders |
Most common type is selective IgA deficiency Prone to respiratory, GI and urinary tract infections |
|
HIV disease and AIDS |
|
|
Hallmark of Aids |
Loss if CD4 cells due to HIV infections |
|
Etiology of HIV |
HIV type 1- most common HIV type 2- endemic in West Africa |
|
HIV is a ___virus meaning __ |
Retrovirus Contains RNA |
|
HIV infects (cells) |
CD4 (helper T-cells) and macrophages (they also have CD4 protiens but fewer than helper T-cells) |
|
Surface glycoprotein on HIV |
gp120 |
|
gp120 binds to ___ and allow__ |
CD4 protiens in CD4 cells and allows virus to enter cell |
|
Viral RNA ___ using __. This becomes __. |
Is transcribed into DNA, Viruses reverse transcriptase enzyme Spliced into host cells DNA |
|
DNA replicated |
Viral and host as viral is permanently appart of host DNA |
|
CDC classification matrix is based on |
CD4 levels Clinical |
|
Catagories based on CD4 levels |
Category 1 >500/microL Category 2 200-499/microL Category 3 < 200/mircoL |
|
Clinical Categories |
A- Asymptomatic or generalized lymphadenopathy B- symptoms of immune deficiency not serious enough to be in C C- includes conditions listed in AIDS surveillance of CDC |
|
Persons in catagory _ or _ considered to have AIDS |
3 or C |
|
Treatment goal is |
To delay disease progression, maintain immune system function, decrease viral load and minimize clinical manifestations |
|
Opportunistic diseases are |
Treated individually with standard protocols |
|
HAART |
Highly Active Antiretroviral therapy Uses combination of drugs |
|
Drugs aimed at stopping replication(4) |
°Nucleoside and ninnucleoside reverse transcriptase inhibitors °Proteases inhibitors °Fusion of entry inhibitors °Integrates strand transfer inhibitors |
|
Proteases inhibitors |
Block enzymes essential for virus replication Work later in infection |
|
Urticaria |
Hives |
|
Pruritus |
Itching |
|
Erythema |
Red skin |
|
Dyspnea |
Difficulty breathing |
|
Bronchial constriction |
Causes wheezing, coughing |